Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 669

Similar articles for PubMed (Select 23658247)

1.

The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.

Karunaratne K, Stevens P, Irving J, Hobbs H, Kilbride H, Kingston R, Farmer C.

Nephrol Dial Transplant. 2013 Aug;28(8):2107-16. doi: 10.1093/ndt/gft093. Epub 2013 May 7.

PMID:
23658247
2.

Treatment of hypertension in chronic kidney disease.

Toto RD.

Semin Nephrol. 2005 Nov;25(6):435-9. Review.

PMID:
16298269
3.

Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care.

Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre CW, Fluck RJ, Taal MW.

BMC Fam Pract. 2013 Jun 24;14:88. doi: 10.1186/1471-2296-14-88.

4.

Management of hypertension in patients with CKD: differences between primary and tertiary care settings.

Minutolo R, De Nicola L, Zamboli P, Chiodini P, Signoriello G, Toderico C, Arfè G, Boschi G, Brancati C, Iaccarino P, Conte G.

Am J Kidney Dis. 2005 Jul;46(1):18-25.

PMID:
15983953
5.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Review.

PMID:
21975774
6.

Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.

Appel LJ, Wright JT Jr, Greene T, Kusek JW, Lewis JB, Wang X, Lipkowitz MS, Norris KC, Bakris GL, Rahman M, Contreras G, Rostand SG, Kopple JD, Gabbai FB, Schulman GI, Gassman JJ, Charleston J, Agodoa LY; African American Study of Kidney Disease and Hypertension Collaborative Research Group.

Arch Intern Med. 2008 Apr 28;168(8):832-9. doi: 10.1001/archinte.168.8.832.

7.

Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease.

Omae K, Ogawa T, Nitta K.

Heart Vessels. 2010 May;25(3):203-8. doi: 10.1007/s00380-009-1188-4. Epub 2010 May 29.

PMID:
20512447
8.

Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study.

Serumaga B, Ross-Degnan D, Avery AJ, Elliott RA, Majumdar SR, Zhang F, Soumerai SB.

BMJ. 2011 Jan 25;342:d108. doi: 10.1136/bmj.d108.

9.

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.

Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, Rabkin SW, Hill MD, Padwal R, Touyz RM, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Moe G, Prasad R, Arnold MO, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, DeChamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Bacon SL, Lindsay P, Gilbert RE, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program.

Can J Cardiol. 2009 May;25(5):287-98. Review.

10.

Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.

Mazzaglia G, Mantovani LG, Sturkenboom MC, Filippi A, Trifirò G, Cricelli C, Brignoli O, Caputi AP.

J Hypertens. 2005 Nov;23(11):2093-100.

PMID:
16208153
11.

Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.

Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.

Nephrol Dial Transplant. 2009 May;24(5):1528-33. doi: 10.1093/ndt/gfn692. Epub 2008 Dec 10.

12.

Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.

Ramsay L, Williams B, Johnston G, MacGregor G, Poston L, Potter J, Poulter N, Russell G.

J Hum Hypertens. 1999 Sep;13(9):569-92. Review.

PMID:
10482967
13.

Clinical outcomes in patients with chronic kidney disease: a 5-year retrospective cohort study at a University Hospital in Japan.

Yamashita T, Yoshida T, Ogawa T, Tsuchiya K, Nitta K.

Clin Exp Nephrol. 2011 Dec;15(6):831-40. doi: 10.1007/s10157-011-0501-6. Epub 2011 Jul 30.

PMID:
21800234
14.

Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study.

Flynn JT, Mitsnefes M, Pierce C, Cole SR, Parekh RS, Furth SL, Warady BA; Chronic Kidney Disease in Children Study Group.

Hypertension. 2008 Oct;52(4):631-7. doi: 10.1161/HYPERTENSIONAHA.108.110635. Epub 2008 Aug 25.

15.

Hypertension, antihypertensive agents and outcomes following renal transplantation.

Tutone VK, Mark PB, Stewart GA, Tan CC, Rodger RS, Geddes CC, Jardine AG.

Clin Transplant. 2005 Apr;19(2):181-92.

PMID:
15740553
16.

The effects of pay for performance on disparities in stroke, hypertension, and coronary heart disease management: interrupted time series study.

Lee JT, Netuveli G, Majeed A, Millett C.

PLoS One. 2011;6(12):e27236. doi: 10.1371/journal.pone.0027236. Epub 2011 Dec 15.

17.

Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.

Jain AK, Cuerden MS, McLeod I, Hemmelgarn B, Akbari A, Tonelli M, Quinn RR, Oliver MJ, Garg AX.

Kidney Int. 2012 Jun;81(12):1248-53. doi: 10.1038/ki.2012.18. Epub 2012 Mar 21.

PMID:
22437415
18.

A retrospective review of diabetic nephropathy patients during referral to the sub-urban nephrology clinic.

Menon R, Mohd Noor FS, Draman CR, Seman MR, Ghani AS.

Saudi J Kidney Dis Transpl. 2012 Sep;23(5):1109-14. doi: 10.4103/1319-2442.100972.

19.

Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.

Chen YR, Yang Y, Wang SC, Chiu PF, Chou WY, Lin CY, Chang JM, Chen TW, Ferng SH, Lin CL.

Nephrol Dial Transplant. 2013 Mar;28(3):671-82. doi: 10.1093/ndt/gfs469. Epub 2012 Dec 6.

20.

Impact of the pay-for-performance contract and the management of hypertension in Scottish primary care: a 6-year population-based repeated cross-sectional study.

Simpson CR, Hannaford PC, Ritchie LD, Sheikh A, Williams D.

Br J Gen Pract. 2011 Jul;61(588):e443-51. doi: 10.3399/bjgp11X583407.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk